ArticleDiscover oncology2022

Tumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).

Jay-Jiguang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.